The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.
about
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2Epidermal growth factor directs sex-specific steroid signaling through Src activationIntegration of the extranuclear and nuclear actions of estrogenEstrogenic control of mitochondrial function and biogenesisInsulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant diseaseTargeting TBP-Associated Factors in Ovarian CancerSustained proliferation in cancer: Mechanisms and novel therapeutic targets17beta-estradiol induces the translocation of the estrogen receptors ESR1 and ESR2 to the cell membrane, MAPK3/1 phosphorylation and proliferation of cultured immature rat Sertoli cellsEstrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation.Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.Membrane initiated estrogen signaling in breast cancer.Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF.Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol.Clathrin Heavy Chain Interacts With Estrogen Receptor α and Modulates 17β-Estradiol SignalingPower of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling indexSuppression of estrogen receptor transcriptional activity by connective tissue growth factor.Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivityEstrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo.Defining the pathway to insulin-like growth factor system targeting in cancer.Estradiol increases ER-negative breast cancer metastasis in an experimental model.Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells.A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer.Insulin-like growth factors and neoplasia.Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.Direct recruitment of insulin receptor and ERK signaling cascade to insulin-inducible gene loci.Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection.Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthoodEvidence for gating roles of protein kinase A and protein kinase C in estradiol-induced luteinizing hormone receptor (lhcgr) expression in zebrafish ovarian follicle cells.Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.Modulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists.The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane.Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer
P2860
Q24294568-D271D591-F91D-4503-97BB-745858CE6766Q24295751-A931E391-8297-4270-AF4F-9A593A024ABAQ24533536-3D45D383-79ED-42A5-8A4B-6B31D630E9CBQ24651145-F986BDB5-85F7-4005-8B0A-117314A42902Q26800001-428BA1A5-C4E6-4616-9F9F-929803F390EDQ26866045-B07E8A8C-9712-40C3-B183-0F7F5E52BA12Q28396388-EFCC087E-7D81-481F-9440-9686B40C843AQ28581907-7AC57B58-C93D-40B2-98EB-80B510BA3C57Q30433113-9191E047-5CE5-4723-97E4-7A4E99078A15Q30434843-F09DEFE1-739B-4A31-9C6D-4397628FADA1Q30435726-2028CAB7-3A1A-46A8-9B03-8002D83D79CCQ30438933-9E88497F-8757-486A-8766-CC5A75867D7DQ30439994-B5DC6901-2D20-40AA-8103-90FD5ABE6DE5Q30440238-4F7C8185-902F-4A4F-A985-C7C23B4AD996Q30441321-56B8CA8D-03D3-4695-B0C1-774A294F919BQ31108919-79CF2319-DAB2-4753-BDA0-0AEF8B2E5B8AQ33564705-8AA8C294-A81C-4904-A25A-FE0FE2E0A056Q33631719-4C6AD473-B24F-4954-B5B2-F96173BD1406Q33717341-4973DEF9-53A1-40D3-87A1-8BFC920E0AD3Q33918227-8409000D-E2DA-450E-B43C-AD150B5F6C51Q33960009-36E4340A-E881-4003-87A5-49298591EAF4Q34022694-A3FD0568-E671-45C8-8851-3C03A83A359AQ34070890-2087410D-E74D-4314-A558-E83E24736619Q34077911-8BF18F6A-5AD5-48FB-9911-ED036217758CQ34107722-0215E2CA-AE29-4132-A5DD-61A19D8C7EC2Q34118227-86B41F82-4929-43EE-97A2-ECB7D687A6F5Q34140383-53FA19F7-8897-4827-84C0-931337E3C89DQ34258178-7B9F1452-8E5D-4BDF-ABCC-0BA081CF119AQ34324699-3F624D08-9E2B-479D-A65A-B774B6E76877Q34330521-05C71055-7DD8-40ED-AE67-FF0688A6FE63Q34352011-5E11C04B-7D00-4792-AB52-E0932A4EC5AEQ34448627-5A3D286D-363B-45FD-B0D6-11D69C9CB62AQ34530662-E41FE9FC-4FF1-42A4-B728-A925345791DDQ34648456-D0128272-2909-43B8-B62D-2CBBB78B4B15Q34703672-CDFDB749-EE60-4405-9A89-F432AF91D514Q34712589-07C80932-92F3-48F7-9750-146F664552D5Q34768276-2766AD79-6DB5-450B-AC21-FA30F1FCCBE3Q35049052-0D77F17E-71F6-4D2C-A6B6-FB9C38523BFFQ35084708-C21A6BE2-43B1-41A0-A08F-23AA853BCCCCQ35085764-BCFA56B3-06EE-4FB9-898A-AF7E59D6658B
P2860
The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@ast
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@en
type
label
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@ast
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@en
prefLabel
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@ast
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@en
P2093
P2860
P356
P1476
The role of Shc and insulin-li ...... alpha to the plasma membrane.
@en
P2093
Christopher J Barnes
Rakesh Kumar
Richard J Santen
Robert X Song
Yongde Bao
Zhenguo Zhang
P2860
P304
P356
10.1073/PNAS.0308334100
P407
P577
2004-02-05T00:00:00Z